Feedback
The current prices are delayed. Login to see live prices.
Glenmark Pharmaceuticals Ltd.
(GLENMARK)
10123456789,301234567890012345678900123456789.8012345678900123456789
-48.15 (-3.57%)
Updated 15:59 21/02 IST
Add
1D
5D
1M
3M
1Y
5Y
MAX
Today's low
₹1,290.05
Today's high
₹1,353.65
52 week low
₹883
52 week high
₹1,830.95
Open
₹1,342.35
Prev Close
₹1,348.95
Volume (shares)
715,656
Total Trading Value
96.54 Cr
Technicals
SMA
Value
Signal
12-SMA
1,408.5
Bearish
20-SMA
1,423.37
Bearish
50-SMA
1,495
Bearish
100-SMA
1,563.19
Bearish
200-SMA
1,482.21
Bearish
Discussions
• Feb 19 11:18 PM
Glenmark Pharmaceuticals Releases Q3 2024 Earnings Call Transcript
• Glenmark Pharmaceuticals held its earnings call on February 17, 20...read more
• Feb 19 11:01 PM
Glenmark Q3 2025 Earnings Call Transcript Available
• The transcript of Glenmark's Q3 earnings call for the period endin...read more
• Feb 17 10:32 PM
Glenmark Pharmaceuticals Schedules Analyst/Investor Meeting
• Glenmark has announced an upcoming Analyst/Institutional Investor ...read more
• Feb 17 10:17 PM
Glenmark Notifies Analyst/Investor Meeting on February 20, 2025
• Glenmark Pharmaceuticals will hold an analyst/institutional invest...read more
• Feb 17 8:55 PM
Glenmark: Q3 FY 2024-25 Earnings Call Recording Available
• Glenmark has confirmed the upload of the Q3 FY 2024-25 earnings ca...read more
• Feb 17 3:48 PM
Buy
Glenmark@1340ce...read more
• Feb 17 1:53 PM
#GLENMARK : The USFDA conducted a GMP inspection at the company's manufacturing facility in Madhya Pradesh from Feb. 3, 2025 to Feb. 14, 2025, and i
• Feb 16 5:50 PM
• Feb 16 5:22 AM
Glenmark Pharma - Quarterly Results
Earnings Update...read more
• Feb 15 5:53 PM
• Feb 15 1:03 AM
Glenmark Pharmaceuticals Q3 FY2025 Results Show Strong 35.1% Revenue Growth
• Glenmark reported a consolidated revenue of Rs. 33,876 million for...read more
• Feb 14 3:00 PM
Glenmark Pharmaceuticals Launches Eye Treatment Latanoprost Ophthalmic Solution
• Glenmark Pharmaceuticals has launched Latanoprost Ophthalmic Solut...read more
• Feb 14 2:45 PM
Glenmark Pharmaceuticals Launches Latanoprost Ophthalmic Solution in USA
• Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic ...read more
• Feb 13 12:30 AM
• Feb 12 3:15 PM
Glenmark Pharmaceuticals Launches New Clindamycin Foam Product in the USA
• Glenmark Pharmaceuticals Inc. has launched Clindamycin Phosphate F...read more
• Feb 12 3:00 PM
Glenmark Pharmaceuticals Launches Clindamycin Phosphate Foam 1% in the USA
• Glenmark Pharmaceuticals Inc. USA has launched Clindamycin Phospha...read more
• Feb 7 12:09 AM
GLENMARK 1500 PE AS GLENMARK SPOT HAS TURNED BEARISH.
ON ICHIMOKU HR CHART , TRADING ABOVE TENKEN SEN 53.68 , ...read more
• Feb 6 2:37 AM
GLENMARK
TIME FRAME DAILY ...read more
• Feb 5 9:48 PM
• Feb 5 7:30 PM
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Enclosed please find herewith the details of Earnings Call slated fo...read more
• Feb 5 12:23 AM
Load More Posts
Frequently Asked Questions (FAQs)
What is the Share Price of Glenmark Pharmaceuticals Ltd. ?
The share prices are volatile and fluctuate throughout the trading hours. The share price of Glenmark Pharmaceuticals Ltd. is Rs 1348.95 as of 21 February 2025.
What is the Market Capitalization of Glenmark Pharmaceuticals Ltd. ?
The current market cap of Glenmark Pharmaceuticals Ltd. is undefined Market capitalisation is calculated by multiplying the current share price with the total number of shares.
What are the PE and PB ratios of Glenmark Pharmaceuticals Ltd.?
Glenmark Pharmaceuticals Ltd. has a price-to-earnings (PE) ratio of undefined and a price-to-book (PB) ratio of undefined.
What is the 52-week high/low of Glenmark Pharmaceuticals Ltd.?
The 52-week high of Glenmark Pharmaceuticals Ltd. is Rs 1830.95 and the 52-week low is Rs 883
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
FrontPage © 2025